NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus MSCs in Patients with Osteoarthritis
Pharmaceutical Investing Cynata CYP-001 Stem Cell Therapy Meets All Safety and Efficacy Endpoints in Phase 1 Trial in GvHD
RUA GOLD Expands High-Grade Intercepts at Depth at Auld Creek: 5.9g/t AuEq over 9m and 48.3g/t AuEq over 1.25m